Chronic kidney disease stages 1–3 increase the risk of venous thrombosis

Summary  Background: End‐stage renal disease has been associated with venous thrombosis (VT). However, the risk of VT in the early stages of chronic kidney disease (CKD) has not yet been investigated. The aim of this study was to investigate whether CKD patients with stage 1–3 disease are at increas...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of thrombosis and haemostasis 2010-11, Vol.8 (11), p.2428-2435
Hauptverfasser: OCAK, G., VERDUIJN, M., VOSSEN, C. Y., LIJFERING, W. M., DEKKER, F. W., ROSENDAAL, F. R., GANSEVOORT, R. T., MAHMOODI, B. K.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Summary  Background: End‐stage renal disease has been associated with venous thrombosis (VT). However, the risk of VT in the early stages of chronic kidney disease (CKD) has not yet been investigated. The aim of this study was to investigate whether CKD patients with stage 1–3 disease are at increased risk of VT. Methods: Eight thousand four hundred and ninety‐five subjects were included in a prospective cohort study, in which renal function and albuminuria were assessed, starting in 1997–1998, and were followed for the occurrence of VT until 1 June 2007. CKD patients were staged according to the Kidney Disease Outcomes Quality Initiative guidelines, on the basis of 24‐h urine albumin excretion and estimated glomerular filtration rates. Objectively verified symptomatic VT was considered to be the endpoint. Results: Of the 8495 subjects, 243 had CKD stage 1, 856 CKD stage 2, and 491 CKD stage 3. During a median follow‐up period of 9.2 years, 128 individuals developed VT. The hazard ratios (HRs) for CKD stages 1, 2 and 3 were, respectively, 2.2 [95% confidence interval (CI) 0.9–5.1], 1.9 (95% CI 1.1–3.1) and 1.6 (95% CI 0.9–2.8) relative to those without CKD after adjustment for age, sex, body mass index, hypertension, diabetes, malignancy, and high‐sensitivity C‐reactive protein. Subjects with CKD stage 3 and albuminuria (≥ 30 mg d–1) had an adjusted HR of 3.0, and subjects with CKD stage 3 without albuminuria had an adjusted HR of 1.0. Conclusions: CKD stages 1 and 2, and CKD stage 3 in the presence of albuminuria, are risk factors for VT. The risk of VT is more related to albuminuria than to impaired glomerular filtration rate.
ISSN:1538-7933
1538-7836
1538-7836
DOI:10.1111/j.1538-7836.2010.04048.x